cookieImage
2026-2027 / PHIN2034-1

Biotechnologies

Concepts and production of protein and oligonucleotide biopharmaceuticals

Living biopharmaceuticals and vaccines - part A: concepts and biosecurity

Living biopharmaceuticals and vaccines - part B: managing the risk of the release of cell and genetic products

Formulation of biopharmaceuticals

Quality control and analytical techniques in biopharmaceuticals, good practice, and legal recommendations - part A: analytical methods

Quality control and analytical techniques in biopharmaceuticals, good practice, and legal recommendations - part B: post-translational modifications

From the laboratory to the pharmacy: legal requirements - part A: patents and industrial protection

From the laboratory to the pharmacy: legal requirements - part B: specifics of regulation around biological drugs including advanced therapies

From the laboratory to the pharmacy: legal requirements - part C: procedure for releasing batches and the legal framework of vaccines

From the laboratory to the pharmacy: legal requirements - part D: introduction to biobanking

Duration

Concepts and production of protein and oligonucleotide biopharmaceuticals : 15h Th
Living biopharmaceuticals and vaccines - part A: concepts and biosecurity : 6h Th
Living biopharmaceuticals and vaccines - part B: managing the risk of the release of cell and genetic products : 3h Th
Formulation of biopharmaceuticals : 15h Th
Quality control and analytical techniques in biopharmaceuticals, good practice, and legal recommendations - part A: analytical methods : 10h Th
Quality control and analytical techniques in biopharmaceuticals, good practice, and legal recommendations - part B: post-translational modifications : 3h Th
From the laboratory to the pharmacy: legal requirements - part A: patents and industrial protection : 5h Th
From the laboratory to the pharmacy: legal requirements - part B: specifics of regulation around biological drugs including advanced therapies : 5h Th
From the laboratory to the pharmacy: legal requirements - part C: procedure for releasing batches and the legal framework of vaccines : 1h Th
From the laboratory to the pharmacy: legal requirements - part D: introduction to biobanking : 3h Th

Number of credits

 Advanced Master in Industrial Pharmacy7 crédits 

Lecturer

Concepts and production of protein and oligonucleotide biopharmaceuticals : David Vermijlen
Living biopharmaceuticals and vaccines - part A: concepts and biosecurity : Véronique Fontaine
Living biopharmaceuticals and vaccines - part B: managing the risk of the release of cell and genetic products : Roland Marini Djang'Eing'A
Formulation of biopharmaceuticals : Rita Vanbever
Quality control and analytical techniques in biopharmaceuticals, good practice, and legal recommendations - part A: analytical methods : Marianne Fillet
Quality control and analytical techniques in biopharmaceuticals, good practice, and legal recommendations - part B: post-translational modifications : Cédric Delporte
From the laboratory to the pharmacy: legal requirements - part A: patents and industrial protection : Patrick Di Stefano
From the laboratory to the pharmacy: legal requirements - part B: specifics of regulation around biological drugs including advanced therapies : Hugues Malonne
From the laboratory to the pharmacy: legal requirements - part C: procedure for releasing batches and the legal framework of vaccines : Lorenzo Tesolin
From the laboratory to the pharmacy: legal requirements - part D: introduction to biobanking : Stéphanie Gofflot

Language(s) of instruction

French language

Organisation and examination

All year long, with partial in January

If a student fails an examination during the first term:

  • They are permitted to resit the assessed subject during the second term (May-June);

Schedule

Schedule online

Units courses prerequisite and corequisite

Prerequisite or corequisite units are presented within each program

Learning unit contents

From the laboratory to the pharmacy: legal requirements - part D: introduction to biobanking

We will describe objectives and activities of a biobank including legal, ethic and technical aspects.

Learning outcomes of the learning unit

Prerequisite knowledge and skills

Planned learning activities and teaching methods

Mode of delivery (face to face, distance learning, hybrid learning)

Course materials and recommended or required readings

Work placement(s)

Organisational remarks and main changes to the course

Contacts

From the laboratory to the pharmacy: legal requirements - part D: introduction to biobanking

Stéphanie Gofflot

04/323.2805

stephanie.gofflot@chuliege.be

Association of one or more MOOCs